Nitric Oxide Regulation of Human Peripheral Blood Mononuclear Cells: Critical Time Dependence and Selectivity for Cytokine versus Chemokine Expression

Journal of Immunology

Volumn 171, Issue 9, 2003, Pages 4809-4815

  Macphail, Sarah E ^a   Gibney, Claire A ^a   Brooks, Bernadette M ^a   Booth, C George ^b   Flanagan, Brian F ^a   Coleman, John W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE CHEMOATTRACTANT PROTEIN 1; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; PHYTOHEMAGGLUTININ; RANTES; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RNA ANALYSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0142148325     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.9.4809     Document Type: Article

References (37)

1. Bogdan, C., M. Röllinghoff, and A. Diefenbach. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64.
2. Coleman, J. W. 2001. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 1:1397.
3. Thomassen, M. J., and M. S. Kavuru. 2001. Human alveolar macrophages and monocytes as a source and target for nitric oxide. Int. Immunopharmacol. 1:1479.
4. Robbins, R. A., P. J. Barnes, D. R. Springall, J. B. Warren, O. J. Kwon, L. D. Buttery, A. J. Wilson, D. A. Geller, and J. M. Polak. 1994. Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Commun. 203:209.
5. Donnelly, L. E., and P. J. Barnes. 2002. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 26:144.
6. Kharitonov, S. A., D. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatics. Lancet 343:133.
7. Singer, I. I., D. W. Kawka, S. Scott, J. R. Weidner, R. A. Mumford, T. E. Riehl, and W. F. Stenson. 1996. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111:871.
8. McInnes, I. B., B. P. Leung, M. Field, X. Q. Wei, F. P. Huang, R. D. Sturrock, A. Kinninmonth, J. Weidner, R. Mumford, and F. Y. Liew. 1996. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med. 184:1519.
9. Liew, F. Y. 1995. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7:396.
10. Kolb, H., and V. Kolb-Bachofen. 1998. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol. Today 19:556.
11. Van der Veen, R. C. 2001. Nitric oxide and T helper cell immunity. Int. Immunopharmacol. 1:1491.
12. Albina, J. E., J. A. Abate, and W. L. Henry. 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:144.
13. Upham, J. W., D. H. Strickland, N. Bilyk, B. W. Robinson, and P. G. Holt. 1995. Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion. Immunology 84:142.
14. Bingisser, R. M., P. A. Tilbrook, P. G. Holt, and U. R. Kees. 1998. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J. Immunol. 160:5729.
15. van der Veen, R. C., T. A. Dietlin, L. Pen, J. D. Gray, and F. M. Hofman. 2000. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-γ is essential but insufficient. Cell. Immunol. 20:125.
16. Merryman, P. F., R. M. Clancy, X. Y. He, and S. B. Abramson. 1993. Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione. Arthritis Rheum. 36:1414.
17. Krenger, W., G. Falzarano, J. Delmonte, Jr., K. M. Snyder, J. C. Byon, and J. L. Ferrara. 1996. Interferon-γ suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood 88:1113.
18. Tarrant, T. K., P. B. Silver, J. L. Wahlsten, L. V. Rizzo, C. C. Chan, B. Wiggert, and R. R. Caspi. 1999. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon γ, nitric oxide, and apoptosis. J. Exp. Med. 189:219.
19. Sahrbacher, U. C., F. Lechner, H. P. Eugster, K. Frei, H. Lassmann, and A. Fontana. 1998. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1332.
20. van der Veen, R. C., T. A. Dietlin, F. M. Hofman, L. Pen, B. H. Segal, and S. M. Holland. 2000. Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice. J. Immunol. 164:5177.
21. Taylor-Robinson, A. W., F. Y. Liew, A. Severn, D. Xu, S. J. McSorley, P. Garside, J. Padron, and R. S. Phillips. 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:980.
22. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.
23. Barnes, P. J., and F. Y. Liew F. Y. 1995. Nitric oxide and asthmatic inflammation. Immunol. Today 16:128.
24. van der Veen, R. C., T. A. Dietlin, L. Pen, and J. D. Gray. 1999. Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretion. Cell. Immunol. 193:194.
25. Bauer, H., T. Jung, T. Tsikas, D. O. Stichtenoth, J. C. Frolich, and C. Neumann C. Nitric oxide inhibits the secretion of T-helper 1 and T-helper 2-associated cytokines in activated T cells. Immunology 90:205.
26. Henson, S. E., T. C. Nichols, V. M. Holers, and D. R. Karp. 1999. The ectoenzyme γ-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes. J. Immunol. 163:1845.
27. Nathan, C., and Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls and controls. Cell 78:915.
28. Stamler, J. S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931.
29. Butler, A. R., F. W. Flitney, and D. L. Williams. 1995. NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol. Sci. 16:18.
30. Wink, D. A., I. Hanbauer, M. B. Grisham, F. Laval, R. W. Nims, J. Laval, J. Cook, R. Pacelli, J. Liebmann, M. Krishna, P. C. Ford, and J. B. Mitchell. 1996. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr. Top. Cell Regul. 34:159.
31. Kröncke, K.-D., K. Fehsel, C. Suschek, and V. Kolb-Bachofen. 2001. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival, Int. Immunopharmacol. 1:1407.
32. Eastmond, N. C., E. M. S. Banks, and J. W. Coleman. 1997. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-γ-induced suppression of exocytosis. J. Immunol. 159:1444.
33. deSchoolmeester, M. L., N. C. Eastmond, R. J. Dearman, I. Kimber, D. A. Basketter, and J. W. Coleman. 1999. Reciprocal effects of interleukin-4 and interferon-γ on immunoglobulin E-mediated mast cell degranulation: a role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate. Immunology 96:138.
34. 15N]-labelled nitrate in biological fluids. Anal. Biochem. 126:131.
35. Raychaudhuri, B., R. Dweik, M. J. Connors, L. Buhrow, A. Malur, J. Drazba, A. C. Arroliga, S. C. Erzurum, M. S., and M. J. Thomassen. 1999. Nitric oxide blocks NFκB activation in alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 21:311.
36. Berendji, D., V. Kolb-Bachofen, P. F. Zipfel, C. Skerka, C. Carlberg, and K.-D. Kröncke. 1999. Zinc finger transcription factors as molecular targets for nitric oxide-mediated immunosuppression: inhibition of IL-2 gene expression in murine lymphocytes. Mol. Med. 5:721.
37. Wang, S., W. Wang, R. A. Wesley, and R. L. Danner. 1999. A Sp1 binding site of the tumor necrosis factor a promoter functions as a nitric oxide response element. J. Biol. Chem. 274:33190.